| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | 74.4 | ¤1,005,926 | US |
| JNJ | Johnson & Johnson | 64.5 | ¤493,401 | US |
| AZN.GB | AstraZeneca PLC | 68.7 | ¤293,792 | GB |
| MRK | Merck & Co., Inc. | 66.1 | ¤270,218 | US |
| NOVO.B.DK | Novo Nordisk A/S Class B | 60.3 | ¤253,038 | DK |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| CORT | Corcept Therapeutics Incorporated. | 43.4 | ¤3,764 | US |
| YPSN.CH | Ypsomed Holding AG | 73.7 | ¤5,805 | CH |
| HLUN.B.DK | H. Lundbeck A/S Class B | 70.2 | ¤6,661 | DK |
| 326030.KR | SK Biopharmaceuticals Co., Ltd. | 77.8 | ¤6,813 | KR |
| ALK.B.DK | ALK-abello A/S Class B | 76.1 | ¤7,825 | DK |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| NOVO.B.DK | Novo Nordisk A/S Class B | 60.3 | 37 | DK |
| BIIB | Biogen Inc. | 60.9 | 31 | US |
| AMGN | Amgen Inc. | 68.1 | 30 | US |
| ISRG | Intuitive Surgical, Inc. | 71.0 | 26 | US |
| REGN | Regeneron Pharmaceuticals, Inc. | 63.9 | 24 | US |
| RMD | ResMed Inc. | 70.2 | 24 | US |
| JNJ | Johnson & Johnson | 64.5 | 23 | US |
| LLY | Eli Lilly and Company | 74.4 | 22 | US |
| 4507.JP | Shionogi & Co., Ltd. | 61.5 | 21 | JP |
| BMY | Bristol-Myers Squibb Company | 64.0 | 21 | US |
| Average Market Cap | ¤86,697 |
| Median Market Cap | ¤21,443 |
| Avg. 3 Mo. Dollar Vol. | ¤365,670,330 |
| Avg. 3 Mo. Trading Vol. | 3,500,982 |
| Last Rebalance Date | 09/22/2025 |
| Companies Replaced | 14 |
| Biggest Industry Increase | Biotechnology |
| Biggest Industry Decrease | Medical/Nursing Services |
| Trailing P/E Ratio (12 Mo.) | 25.5 |
| Forward P/E Ratio (12 Mo.) | 20.2 |
| Price/Book Ratio | 5.7 |
| Avg. Revenue Chg. - 3 Yr | 39.4% |
| Avg. Op. Income Chg. - 3 Yr. | 76.8% |
| Avg. EPS Growth - 3 Yr. | 22.2% |
| Avg. EPS Growth - 1 Yr. | 15.6% |
| Avg. Operating Margin | 25.8% |
| Avg. LT Debt to Total Capital | 20.2% |
| Avg. Return on Equity | 20.0% |
| Dividend Yield | 0.3% |
| Developed Markets (ex-Australia) Health Care Index | 64.92 |
| United States Of America | 62.0% |
| Japan | 12.0% |
| Denmark | 8.0% |
| Korea, Republic Of | 6.0% |
| Netherlands | 2.0% |
| Sweden | 2.0% |
| Finland | 2.0% |
| United Kingdom | 2.0% |
| Belgium | 2.0% |
| Switzerland | 2.0% |
